WaveMan · Form 4
Perceptive Advisors LLC insider trades
> Search tickers & screens ⌘K
LIVE

Perceptive Advisors LLC insider trades

Perceptive Advisors LLC has filed 38 Form 4s with the SEC that we hold, for Aldeyra Therapeutics, Inc. (ALDX) (10% owner), LeonaBio, Inc. (LONA) (Director, 10% owner), SLNO (10% owner) and Acrivon Therapeutics, Inc. (ACRV) (10% owner), among 24 companies in all. Across all of them we count 41 purchases worth $76.4M and 25 sales worth $16.7M reported on Form 4. In the last 12 months: 1 purchase ($7.5M) and 6 sales ($182.5K). The largest single trade was a purchase of 5,924,170 shares of Lyra Therapeutics, Inc. worth $25.0M, dated 2022-04-12. The first filing on our record is dated 2021-08-17 and the latest 2026-08-27.

Aldeyra Therapeutics, Inc. (ALDX)

10% owner · 3 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-07-29P, purchase reported on Form 4222,123$1.1M2022-08-02
2022-08-01P, purchase reported on Form 4144,185$728.1K2022-08-03
2022-08-09P, purchase reported on Form 4100,000$750.0K2022-08-11
2022-08-10P, purchase reported on Form 415,000$117.8K2022-08-11

LeonaBio, Inc. (LONA)

Director, 10% owner · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

SLNO

10% owner · 3 filings · 21 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-19P, purchase reported on Form 425,200$116.4K2023-05-23
2023-05-22P, purchase reported on Form 427,300$139.8K2023-05-23
2023-05-23P, purchase reported on Form 427,500$149.9K2023-05-23
2023-06-02P, purchase reported on Form 464,630$383.3K2023-06-06
2023-06-05P, purchase reported on Form 478,468$469.2K2023-06-06
2023-06-06P, purchase reported on Form 4200$1.2K2023-06-06
2023-09-26P, purchase reported on Form 45,703$43.6K2023-09-28
2023-09-26P, purchase reported on Form 413,687$113.6K2023-09-28
2023-09-26P, purchase reported on Form 436,939$775.7K2023-09-28
2023-09-26P, purchase reported on Form 4117,996$2.4M2023-09-28
2023-09-26P, purchase reported on Form 488,685$1.7M2023-09-28
2023-09-26P, purchase reported on Form 452,691$961.1K2023-09-28
2023-09-26P, purchase reported on Form 45,419$51.6K2023-09-28
2023-09-26P, purchase reported on Form 437,911$418.9K2023-09-28
2023-09-26P, purchase reported on Form 477,837$919.3K2023-09-28
2023-09-26P, purchase reported on Form 442,838$550.0K2023-09-28
2023-09-26P, purchase reported on Form 430,511$424.7K2023-09-28
2023-09-26P, purchase reported on Form 43,326$48.6K2023-09-28
2023-09-26P, purchase reported on Form 427,769$444.3K2023-09-28
2023-09-26P, purchase reported on Form 475,477$1.3M2023-09-28
2023-09-28P, purchase reported on Form 4250,000$5.0M2023-09-28

Acrivon Therapeutics, Inc. (ACRV)

10% owner · 2 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-04-25S, sale reported on Form 41,054,669$2.1M2025-04-29
2025-04-28S, sale reported on Form 4215,283$335.8K2025-04-29
2025-04-29S, sale reported on Form 4250,000$352.5K2025-04-29
2025-04-30S, sale reported on Form 4437,881$617.4K2025-05-01
2025-05-01S, sale reported on Form 4298,886$400.5K2025-05-01

CERE

Director · 2 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-23P, purchase reported on Form 444,437$1.1M2021-08-25
2021-08-24P, purchase reported on Form 469,761$1.9M2021-08-25
2021-08-25P, purchase reported on Form 461,387$1.8M2021-08-25

Immatics N.V. (IMTX)

Director · 2 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-08-26P, purchase reported on Form 4863,060$7.5M2026-08-27

LianBio (LIAN)

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Lyra Therapeutics, Inc. (LYRA)

10% owner · 2 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-04-12P, purchase reported on Form 45,924,170$25.0M2022-04-14
2025-11-11S, sale reported on Form 4537$2.3K2025-11-13
2025-11-11S, sale reported on Form 44,783$20.6K2025-11-13
2025-11-12S, sale reported on Form 4883$3.6K2025-11-13
2025-11-12S, sale reported on Form 47,862$31.9K2025-11-13
2025-11-13S, sale reported on Form 428,597$111.5K2025-11-13
2025-11-13S, sale reported on Form 43,213$12.5K2025-11-13

MeiraGTx Holdings plc (MGTX)

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Nautilus Biotechnology, Inc. (NAUT)

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Verrica Pharmaceuticals Inc. (VRCA)

10% owner · 2 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-12-15P, purchase reported on Form 4500,000$3.0M2023-12-19
2023-12-18P, purchase reported on Form 4456,923$2.5M2023-12-19
2023-12-19P, purchase reported on Form 4277,008$1.5M2023-12-19
2023-12-21P, purchase reported on Form 4200,000$1.2M2023-12-26
2023-12-22P, purchase reported on Form 4250,000$1.7M2023-12-26
2023-12-26P, purchase reported on Form 454,652$354.7K2023-12-26

AGRX

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-10-13P, purchase reported on Form 45,734,560$4.9M2021-10-15

ALBO

10% owner · 1 filing · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-10-11S, sale reported on Form 4100,340$2.3M2022-10-13
2022-10-11S, sale reported on Form 45,415$134.2K2022-10-13
2022-10-11S, sale reported on Form 438,310$926.3K2022-10-13
2022-10-12S, sale reported on Form 47,240$168.2K2022-10-13
2022-10-12S, sale reported on Form 489,979$2.0M2022-10-13
2022-10-13S, sale reported on Form 4406$9.3K2022-10-13
2022-10-13S, sale reported on Form 4178,726$3.9M2022-10-13

ATXS

Director · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-12-21P, purchase reported on Form 4740,000$4.6M2023-12-22

Adagio Medical Holdings, Inc. (ADGM)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Adma Biologics, INC. (ADMA)

10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-24S, sale reported on Form 4250,000$315.0K2021-09-29
2021-09-27S, sale reported on Form 4250,000$307.5K2021-09-29

CEMI

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-04-04P, purchase reported on Form 4195,938$86.2K2023-04-06
2023-04-05P, purchase reported on Form 4217,500$97.9K2023-04-06
2023-04-06P, purchase reported on Form 4339,000$149.2K2023-04-06

Cypherpunk Technologies INC. (LPTX)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Freenome, Inc. (FRNM)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Kardigan, Inc. (KARD)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

QTNT

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-10-31S, sale reported on Form 48,255,607$660.4K2022-11-02

Solid Biosciences Inc. (SLDB)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

VBIV

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-04-04S, sale reported on Form 44,810,623$769.7K2023-04-06
2023-04-05S, sale reported on Form 41,832,563$238.2K2023-04-06
2023-04-06S, sale reported on Form 44,251,563$467.7K2023-04-06

Yarrow Bioscience, Inc. (VYNE)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-08-13S, sale reported on Form 4250,000$460.0K2021-08-17
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1224962) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms